Abstract
A growing list of common and rare genetic risk variants are being implicated in schizophrenia susceptibility. As with other complex genetic disorders most of the variance in genetic risk is still to be attributed. What can be learned from progress to date? The available data challenges how we conceptualize schizophrenia and suggests strong aetiological links with other psychiatric and developmental disorders. With the identification of rare copy number risk variants implicating specific genes (e.g. VIPR2 and NRXN1) it is increasingly possible to investigate molecular aetiology in patient subgroups to establish whether schizophrenia represents one or many different disease processes. This review summarizes recent research progress and suggests how the tools of modern genomics and neuroscience can be applied to best understand this devastating disorder.
Keywords: Copy Number Variation, DNA variants, neurodevelopmental disorders, psychosis, schizophrenia, GWAS, MHC, PHENOTYPE, psychiatric disorders, Variants
Current Genomics
Title: The Shock of the New: Progress in Schizophrenia Genomics
Volume: 12 Issue: 7
Author(s): Susan Moore, Eric Kelleher and Aiden Corvin
Affiliation:
Keywords: Copy Number Variation, DNA variants, neurodevelopmental disorders, psychosis, schizophrenia, GWAS, MHC, PHENOTYPE, psychiatric disorders, Variants
Abstract: A growing list of common and rare genetic risk variants are being implicated in schizophrenia susceptibility. As with other complex genetic disorders most of the variance in genetic risk is still to be attributed. What can be learned from progress to date? The available data challenges how we conceptualize schizophrenia and suggests strong aetiological links with other psychiatric and developmental disorders. With the identification of rare copy number risk variants implicating specific genes (e.g. VIPR2 and NRXN1) it is increasingly possible to investigate molecular aetiology in patient subgroups to establish whether schizophrenia represents one or many different disease processes. This review summarizes recent research progress and suggests how the tools of modern genomics and neuroscience can be applied to best understand this devastating disorder.
Export Options
About this article
Cite this article as:
Moore Susan, Kelleher Eric and Corvin Aiden, The Shock of the New: Progress in Schizophrenia Genomics, Current Genomics 2011; 12 (7) . https://dx.doi.org/10.2174/138920211797904089
| DOI https://dx.doi.org/10.2174/138920211797904089 |
Print ISSN 1389-2029 |
| Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Extracellular Matrix of Blood Vessels
Current Pharmaceutical Design Obstructive Sleep Apnea Syndrome: From Phenotype to Genetic Basis
Current Genomics Transforming Growth Factor-β Signaling in Motor Neuron Diseases
Current Molecular Medicine RNA-Mediated Therapeutics: From Gene Inactivation to Clinical Application
Current Topics in Medicinal Chemistry Recent Advancement in the Treatment of Cardiovascular Diseases: Conventional Therapy to Nanotechnology
Current Pharmaceutical Design Significance of Hemodynamics Biomarkers, Tissue Biomechanics and Numerical Simulations in the Pathogenesis of Ascending Thoracic Aortic Aneurysms
Current Pharmaceutical Design Complications of the Chest Wall and the Respiratory System After Surgery and Functional Performance
Current Respiratory Medicine Reviews Chest Pain in Children
Current Pediatric Reviews Cardiovascular Diseases in Pregnancy - A Brief Overview
Current Cardiology Reviews Clinical Characteristics and Treatment of Cardiomyopathies in Children
Current Cardiology Reviews Aortic Dissection: A Review of the Pathophysiology, Management and Prospective Advances
Current Cardiology Reviews Big Data and Genome Editing Technology: A New Paradigm of Cardiovascular Genomics
Current Cardiology Reviews Somatic Genome Variations in Health and Disease
Current Genomics Novel Insights into Complex Cardiovascular Pathologies using 4D Flow Analysis by Cardiovascular Magnetic Resonance Imaging
Current Pharmaceutical Design Climate Change, Climate Variability and Brucellosis
Recent Patents on Anti-Infective Drug Discovery Genetics of Congenital Heart Disease
Current Cardiology Reviews Targeting Fibrosis in Systemic Sclerosis
Endocrine, Metabolic & Immune Disorders - Drug Targets Molecular Basis of Young Ischemic Stroke
Current Medicinal Chemistry Pleiotropic Effects of ARB in Vascular Metabolism - Focusing on Atherosclerosis-Based Cardiovascular Disease
Current Vascular Pharmacology Big Data for Treatment Planning: Pathways and Possibilities for Smart Healthcare Systems
Current Medical Imaging





